Miller’s Appointment Gives Kennedy’s MAHA Agenda New Momentum
On November 16, Kennedy’s supporters were signaling renewed confidence in his Make America Healthy Again agenda, following Miller’s appointment as White House chief of staff. At a MAHA event held after Democrats took control of both chambers of Congress in the midterms, Kennedy said the Senate no longer had leverage over him.
Kennedy told activists that he and Miller had met with their wives at Miller’s home about two weeks earlier. He said Miller described himself as even more radical than Kennedy on MAHA and wanted to make the movement his top priority after the midterms. Kennedy responded to Miller’s appointment by posting that it was time to “unleash the Kraken.”
Kennedy aide Stefanie Spear has told department staff that Miller’s support means the agenda can move forward, according to a person familiar with the department. Other people familiar with the matter said Miller’s promotion would give Kennedy more room to pursue his plans.
Public health experts have raised concerns, particularly about vaccines. Miller backed President Donald Trump’s August executive order to revise the childhood vaccine schedule and separate the combined MMR vaccine into individual doses. Medical groups criticized the order, which has not been finalized. A Democratic-aligned science advocacy group’s president called Miller’s appointment a sign the administration would intensify its anti-vaccine agenda.
The administration’s vaccine proposals could face public resistance: KFF polling found about four in 10 voters approved of its handling of immunizations. A memo from Miller’s office also requires staff to obtain counsel’s approval before holding on-site policy meetings with registered lobbyists.
Miller’s Rise Signals a Deeper Push Against Vaccine Science
Stephen Miller’s arrival as White House chief of staff is a warning to public health experts: Kennedy’s MAHA agenda may now have a powerful ally at the top of the administration. Kennedy told activists that Miller wants to make MAHA his top priority, and supporters inside the health department are signaling that the agenda can advance.
The concern is not abstract. Miller stood with President Donald Trump in August as Trump signed an executive order seeking to alter the childhood vaccine schedule and split the combined MMR vaccine into separate doses. Medical groups condemned the move, which has not been finalized. A Democratic-aligned science advocacy group’s president said Miller’s appointment signaled a plan to intensify the administration’s anti-vaccine agenda.
The public is not broadly sold on the administration’s immunization approach: KFF polling found only about four in 10 voters approved of it. Kennedy’s new political backing does not resolve the concerns raised by medical groups; it could make the proposed changes harder to stop.
Miller’s office has also imposed a new requirement for White House staff to get counsel’s approval before on-site policy meetings with registered lobbyists. But that change does not answer the central public health question: whether the administration will press ahead with vaccine policies medical organizations have criticized.
Miller’s Appointment Clears Space for Kennedy’s Health Agenda
After Republicans lost control of both chambers of Congress, Kennedy told MAHA supporters that the Senate no longer had leverage over him. Miller’s appointment as White House chief of staff has further energized Kennedy’s allies, who see the new chief of staff as a strong backer of the movement.
Kennedy told activists that Miller wants to make MAHA his top priority. Miller’s arrival is expected to give Kennedy greater latitude to advance his plans, while Kennedy celebrated the appointment by declaring it was time to “unleash the Kraken.” Miller’s office has also required White House staff to seek counsel’s approval before holding on-site policy meetings with registered lobbyists, a shift from the previous chief of staff’s approach.
Critics are concentrating on vaccines. Miller supported Trump’s August executive order to revise the childhood vaccine schedule and separate the combined MMR vaccine into individual doses. Medical groups criticized the order, which has not been finalized, and a Democratic-aligned advocacy group accused the administration of pursuing a reckless anti-vaccine agenda.
The dispute puts MAHA’s public health proposals under scrutiny as Kennedy’s allies anticipate greater room to act. KFF polling found about four in 10 voters approved of the administration’s handling of immunizations, a figure that signals a challenge for its vaccine plans.






